Medizone International, Inc. (OTCMKTS:MZEI) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
discuss recent management changes and commercial strategy with
investors. During the webcast, management made reference to
slides included in an Investor Update furnished to the Commission
with the Companys Current Report on Form 8-K filed on March 1,
2017 and posted on the Companys website.
Securities and Exchange Commission the following documents
attached as exhibits to this Current Report on Form 8-K and
incorporated by reference to this Item 7.01: the conference call
script attached as Exhibit 99.1 hereto.
information in Item 7.01 of this Current Report on Form 8-K,
including Exhibits 99.1 shall not be deemed filed for the
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, or otherwise subject to the liabilities of that section.
The information in Item 7.01 of this Current Report on Form 8-K
shall not be incorporated by reference into any filing or other
document to the Securities Act of 1933, as amended, except as may
be expressly set forth by specific reference in such filing or
document.
|
Exhibit Number
|
Description
|
|
|
99.1
|
Conference Call Script, dated March 2, 2017
|
|
About Medizone International, Inc. (OTCMKTS:MZEI)
Medizone International, Inc. is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The Company’s AsepticSure is an ozone-based technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane. The Company is developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures. AsepticSure has completed safety and preliminary operational trials. During the tests, AsepticSure has demonstrated a turnaround time of approximately 90 minutes for disinfection and reoccupation of the hospital rooms. Medizone International, Inc. (OTCMKTS:MZEI) Recent Trading Information
Medizone International, Inc. (OTCMKTS:MZEI) closed its last trading session up +0.005 at 0.135 with 39,639 shares trading hands.